Why is Insulet Corp. ?
- The company has been able to generate a Return on Capital Employed (avg) of 11.86% signifying low profitability per unit of total capital (equity and debt)
- NET PROFIT(9M) At USD 276.71 MM has Grown at -24.56%
- ROCE(HY) Lowest at 18.12%
- INTEREST(Q) At USD 19.6 MM has Grown at 25.64%
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -10.15%, its profits have fallen by -14.9%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Along with generating -10.15% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
How much should you hold?
- Overall Portfolio exposure to Insulet Corp. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Insulet Corp. for you?
High Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at USD 569.3 MM
Lowest at 18.86 %
Fallen by -0.06% (YoY
Highest at 1.71 times
Highest at USD 783.8 MM
Highest at USD 176.9 MM
Highest at USD 140.1 MM
Highest at USD 101.53 MM
Highest at USD 1.44
At USD 276.71 MM has Grown at -24.56%
Lowest at 18.12%
At USD 19.6 MM has Grown at 25.64%
Here's what is working for Insulet Corp.
Operating Cash Flows (USD MM)
Debt-Equity Ratio
Net Sales (USD MM)
Net Sales (USD MM)
Operating Profit (USD MM)
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
EPS (USD)
Inventory Turnover Ratio
Raw Material Cost as a percentage of Sales
Depreciation (USD MM)
Here's what is not working for Insulet Corp.
Interest Paid (USD MM)






